{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/346947302"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/199213708" ] } },

    { "id" : "http://webisa.webdatacommons.org/199213708"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Some of the reports covered in this review have suggested that hematopoietic stem cells can serve as an alternative to embryonic stem cells for tissue replacement after injury or disease, such as stroke and heart infarct, Parkinson disease, cystic fibrosis, muscular dystrophy, and congenital liver diseases." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bloodjournal.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/436841068"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/199213708" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/449506125"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/199213708"] } } }
